Laboratory Corporation of America Holdings Financial Statements (LH)
|
|
Report date
|
|
|
25.02.2022 |
31.12.2022 |
28.02.2023 |
31.12.2023 |
26.02.2024 |
|
29.10.2024 |
Currency
|
|
|
USD |
USD |
USD |
USD |
USD |
|
USD |
Financial report URL
|
|
|
|
|
|
|
|
|
|
|
Revenue, bln rub |
? |
|
16 121 |
14 877 |
14 877 |
12 162 |
12 162 |
|
13 006 |
Operating Income, bln rub |
|
|
3 260 |
2 129 |
1 774 |
1 124 |
725.6 |
|
1 109 |
EBITDA, bln rub |
? |
|
4 279 |
2 395 |
1 954 |
1 701 |
1 349 |
|
1 435 |
Net profit, bln rub |
? |
|
2 377 |
1 279 |
1 279 |
418.0 |
418.0 |
|
749.2 |
|
OCF, bln rub |
? |
|
3 110 |
1 956 |
1 956 |
1 328 |
1 328 |
|
1 677 |
CAPEX, bln rub |
? |
|
460.4 |
481.9 |
481.9 |
453.6 |
453.6 |
|
488.0 |
FCF, bln rub |
? |
|
2 649 |
1 474 |
1 474 |
874.1 |
874.1 |
|
1 189 |
Dividend payout, bln rub
|
|
|
0.000 |
195.2 |
195.2 |
254.0 |
254.0 |
|
241.8 |
|
Ordinary share dividend yield, %
|
|
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
|
0.00% |
Dividend payout ratio, %
|
|
|
0.00% |
15.3% |
15.3% |
60.8% |
60.8% |
|
32.3% |
|
OPEX, bln rub |
|
|
2 322 |
2 256 |
2 256 |
2 021 |
2 021 |
|
2 317 |
Cost of production, bln rub |
|
|
10 497 |
10 492 |
10 492 |
9 017 |
8 797 |
|
9 406 |
R&D, bln rub |
|
|
0.000 |
0.000 |
0.000 |
0.000 |
0.000 |
|
0.000 |
Interest expenses, bln rub |
|
|
212.1 |
180.3 |
180.3 |
199.6 |
199.6 |
|
196.0 |
|
Assets, bln rub |
|
|
20 385 |
20 155 |
20 155 |
16 725 |
16 725 |
|
18 613 |
Net Assets, bln rub |
? |
|
10 273 |
10 097 |
10 097 |
7 875 |
7 875 |
|
8 170 |
Debt, bln rub |
|
|
6 343 |
6 295 |
6 295 |
5 954 |
5 954 |
|
7 719 |
Cash, bln rub |
|
|
1 473 |
430.0 |
430.0 |
536.8 |
536.8 |
|
1 517 |
Net debt, bln rub |
|
|
4 870 |
5 865 |
5 865 |
5 417 |
5 417 |
|
6 202 |
|
Ordinary share price, rub |
|
|
269.9 |
235.5 |
202.3 |
227.3 |
227.3 |
|
199.0 |
Number of ordinary shares, mln |
|
|
96.7 |
91.1 |
91.1 |
87.6 |
87.1 |
|
84.0 |
|
Market cap, bln rub |
|
|
26 102 |
21 452 |
18 429 |
19 911 |
19 797 |
|
16 713 |
EV, bln rub |
? |
|
30 972 |
27 317 |
24 294 |
25 328 |
25 214 |
|
22 915 |
Book value, bln rub |
|
|
-1 422 |
-1 971 |
-1 971 |
-1 610 |
-1 610 |
|
-1 853 |
|
EPS, rub |
? |
|
24.6 |
14.0 |
14.0 |
4.77 |
4.80 |
|
8.92 |
FCF/share, rub |
|
|
27.4 |
16.2 |
16.2 |
9.98 |
10.0 |
|
14.2 |
BV/share, rub |
|
|
-14.7 |
-21.6 |
-21.6 |
-18.4 |
-18.5 |
|
-22.1 |
|
EBITDA margin, % |
? |
|
26.5% |
16.1% |
13.1% |
14.0% |
11.1% |
|
11.0% |
Net margin, % |
? |
|
14.7% |
8.60% |
8.60% |
3.44% |
3.44% |
|
5.76% |
FCF yield, % |
? |
|
10.1% |
6.87% |
8.00% |
4.39% |
4.42% |
|
7.11% |
ROE, % |
? |
|
23.1% |
12.7% |
12.7% |
5.31% |
5.31% |
|
9.17% |
ROA, % |
? |
|
11.7% |
6.35% |
6.35% |
2.50% |
2.50% |
|
4.03% |
|
P/E |
? |
|
11.0 |
16.8 |
14.4 |
47.6 |
47.4 |
|
22.3 |
P/FCF |
|
|
9.85 |
14.6 |
12.5 |
22.8 |
22.6 |
|
14.1 |
P/S |
? |
|
1.62 |
1.44 |
1.24 |
1.64 |
1.63 |
|
1.29 |
P/BV |
? |
|
-18.4 |
-10.9 |
-9.35 |
-12.4 |
-12.3 |
|
-9.02 |
EV/EBITDA |
? |
|
7.24 |
11.4 |
12.4 |
14.9 |
18.7 |
|
16.0 |
Debt/EBITDA |
|
|
1.14 |
2.45 |
3.00 |
3.18 |
4.01 |
|
4.32 |
|
R&D/CAPEX, % |
|
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
|
0 |
|
CAPEX/Revenue, % |
|
|
2.86% |
3.24% |
3.24% |
3.73% |
3.73% |
|
3.75% |
|
Laboratory Corporation of America Holdings shareholders |